Trial
NCT01385293
BKM120 in Metastatic Castration-resistant Prostate Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Andrew J. Armstrong, MD
Collaborators
Novartis Pharmaceuticals
Condition
Prostate Cancer
Intervention
BKM120
Why stopped
The trial was stopped at the first stage due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-19